nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—ADRB1—dilated cardiomyopathy	0.507	0.543	CbGaD
Levobunolol—ADRB2—dilated cardiomyopathy	0.427	0.457	CbGaD
Levobunolol—Diabetic—Lisinopril—dilated cardiomyopathy	0.00372	0.0673	CcSEcCtD
Levobunolol—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.00257	0.0465	CcSEcCtD
Levobunolol—Lethargy—Spironolactone—dilated cardiomyopathy	0.00225	0.0408	CcSEcCtD
Levobunolol—Ataxia—Spironolactone—dilated cardiomyopathy	0.00208	0.0376	CcSEcCtD
Levobunolol—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00176	0.0318	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00169	0.0305	CcSEcCtD
Levobunolol—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00144	0.0261	CcSEcCtD
Levobunolol—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00138	0.025	CcSEcCtD
Levobunolol—Alopecia—Spironolactone—dilated cardiomyopathy	0.00135	0.0244	CcSEcCtD
Levobunolol—Lethargy—Furosemide—dilated cardiomyopathy	0.00123	0.0222	CcSEcCtD
Levobunolol—Confusional state—Spironolactone—dilated cardiomyopathy	0.00109	0.0198	CcSEcCtD
Levobunolol—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00104	0.0187	CcSEcCtD
Levobunolol—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00099	0.0179	CcSEcCtD
Levobunolol—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000924	0.0167	CcSEcCtD
Levobunolol—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00092	0.0166	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000918	0.0166	CcSEcCtD
Levobunolol—Diplopia—Lisinopril—dilated cardiomyopathy	0.000902	0.0163	CcSEcCtD
Levobunolol—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000895	0.0162	CcSEcCtD
Levobunolol—Urticaria—Spironolactone—dilated cardiomyopathy	0.000862	0.0156	CcSEcCtD
Levobunolol—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000857	0.0155	CcSEcCtD
Levobunolol—Ataxia—Lisinopril—dilated cardiomyopathy	0.000848	0.0153	CcSEcCtD
Levobunolol—Timolol—ADRB1—dilated cardiomyopathy	0.000841	0.0966	CrCbGaD
Levobunolol—Visual impairment—Furosemide—dilated cardiomyopathy	0.000801	0.0145	CcSEcCtD
Levobunolol—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0008	0.0145	CcSEcCtD
Levobunolol—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000786	0.0142	CcSEcCtD
Levobunolol—Pruritus—Spironolactone—dilated cardiomyopathy	0.000768	0.0139	CcSEcCtD
Levobunolol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000767	0.0139	CcSEcCtD
Levobunolol—Carteolol—ADRB1—dilated cardiomyopathy	0.000749	0.0861	CrCbGaD
Levobunolol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000743	0.0134	CcSEcCtD
Levobunolol—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000743	0.0134	CcSEcCtD
Levobunolol—Dizziness—Spironolactone—dilated cardiomyopathy	0.000718	0.013	CcSEcCtD
Levobunolol—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000718	0.013	CcSEcCtD
Levobunolol—Timolol—ADRB2—dilated cardiomyopathy	0.000707	0.0813	CrCbGaD
Levobunolol—Depression—Lisinopril—dilated cardiomyopathy	0.000693	0.0125	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000689	0.0125	CcSEcCtD
Levobunolol—Headache—Spironolactone—dilated cardiomyopathy	0.00068	0.0123	CcSEcCtD
Levobunolol—Nadolol—ADRB1—dilated cardiomyopathy	0.000668	0.0768	CrCbGaD
Levobunolol—Nausea—Spironolactone—dilated cardiomyopathy	0.000645	0.0117	CcSEcCtD
Levobunolol—Bupranolol—ADRB1—dilated cardiomyopathy	0.000637	0.0732	CrCbGaD
Levobunolol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000635	0.0115	CcSEcCtD
Levobunolol—Carteolol—ADRB2—dilated cardiomyopathy	0.00063	0.0724	CrCbGaD
Levobunolol—Salbutamol—ADRB1—dilated cardiomyopathy	0.000599	0.0688	CrCbGaD
Levobunolol—Confusional state—Furosemide—dilated cardiomyopathy	0.000596	0.0108	CcSEcCtD
Levobunolol—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00059	0.0107	CcSEcCtD
Levobunolol—Penbutolol—ADRB1—dilated cardiomyopathy	0.000583	0.067	CrCbGaD
Levobunolol—Shock—Furosemide—dilated cardiomyopathy	0.000581	0.0105	CcSEcCtD
Levobunolol—Nadolol—ADRB2—dilated cardiomyopathy	0.000562	0.0645	CrCbGaD
Levobunolol—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000557	0.0101	CcSEcCtD
Levobunolol—Hypotension—Furosemide—dilated cardiomyopathy	0.000552	0.00998	CcSEcCtD
Levobunolol—Alopecia—Lisinopril—dilated cardiomyopathy	0.000551	0.00997	CcSEcCtD
Levobunolol—Bupranolol—ADRB2—dilated cardiomyopathy	0.000536	0.0616	CrCbGaD
Levobunolol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00053	0.00959	CcSEcCtD
Levobunolol—Pain—Furosemide—dilated cardiomyopathy	0.000505	0.00913	CcSEcCtD
Levobunolol—Salbutamol—ADRB2—dilated cardiomyopathy	0.000504	0.0579	CrCbGaD
Levobunolol—Penbutolol—ADRB2—dilated cardiomyopathy	0.00049	0.0563	CrCbGaD
Levobunolol—Syncope—Lisinopril—dilated cardiomyopathy	0.000487	0.00881	CcSEcCtD
Levobunolol—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000487	0.0088	CcSEcCtD
Levobunolol—Palpitations—Lisinopril—dilated cardiomyopathy	0.00048	0.00868	CcSEcCtD
Levobunolol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000477	0.00863	CcSEcCtD
Levobunolol—Urticaria—Furosemide—dilated cardiomyopathy	0.000469	0.00848	CcSEcCtD
Levobunolol—Chest pain—Lisinopril—dilated cardiomyopathy	0.000462	0.00836	CcSEcCtD
Levobunolol—Confusional state—Lisinopril—dilated cardiomyopathy	0.000447	0.00808	CcSEcCtD
Levobunolol—Shock—Lisinopril—dilated cardiomyopathy	0.000436	0.00788	CcSEcCtD
Levobunolol—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000435	0.00787	CcSEcCtD
Levobunolol—Asthenia—Furosemide—dilated cardiomyopathy	0.000424	0.00766	CcSEcCtD
Levobunolol—Pindolol—ADRB1—dilated cardiomyopathy	0.00042	0.0483	CrCbGaD
Levobunolol—Pruritus—Furosemide—dilated cardiomyopathy	0.000418	0.00756	CcSEcCtD
Levobunolol—Hypotension—Lisinopril—dilated cardiomyopathy	0.000414	0.00749	CcSEcCtD
Levobunolol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000404	0.00731	CcSEcCtD
Levobunolol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000398	0.0072	CcSEcCtD
Levobunolol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000395	0.00714	CcSEcCtD
Levobunolol—Dizziness—Furosemide—dilated cardiomyopathy	0.000391	0.00706	CcSEcCtD
Levobunolol—Pain—Lisinopril—dilated cardiomyopathy	0.000379	0.00685	CcSEcCtD
Levobunolol—Headache—Furosemide—dilated cardiomyopathy	0.00037	0.00669	CcSEcCtD
Levobunolol—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000365	0.0066	CcSEcCtD
Levobunolol—Pindolol—ADRB2—dilated cardiomyopathy	0.000353	0.0406	CrCbGaD
Levobunolol—Urticaria—Lisinopril—dilated cardiomyopathy	0.000352	0.00637	CcSEcCtD
Levobunolol—Nausea—Furosemide—dilated cardiomyopathy	0.000351	0.00634	CcSEcCtD
Levobunolol—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000327	0.0059	CcSEcCtD
Levobunolol—Asthenia—Lisinopril—dilated cardiomyopathy	0.000318	0.00575	CcSEcCtD
Levobunolol—Pruritus—Lisinopril—dilated cardiomyopathy	0.000314	0.00567	CcSEcCtD
Levobunolol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000303	0.00548	CcSEcCtD
Levobunolol—Dizziness—Lisinopril—dilated cardiomyopathy	0.000293	0.0053	CcSEcCtD
Levobunolol—Headache—Lisinopril—dilated cardiomyopathy	0.000278	0.00502	CcSEcCtD
Levobunolol—Nausea—Lisinopril—dilated cardiomyopathy	0.000263	0.00476	CcSEcCtD
Levobunolol—ADRB2—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.000255	0.116	CbGpPWpGaD
Levobunolol—Propranolol—ADRB1—dilated cardiomyopathy	0.000229	0.0263	CrCbGaD
Levobunolol—ADRB1—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.000211	0.0964	CbGpPWpGaD
Levobunolol—Propranolol—ADRB2—dilated cardiomyopathy	0.000193	0.0221	CrCbGaD
Levobunolol—ADRB2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	9.02e-05	0.0412	CbGpPWpGaD
Levobunolol—ADRB2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	7.59e-05	0.0346	CbGpPWpGaD
Levobunolol—ADRB1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	7.47e-05	0.0341	CbGpPWpGaD
Levobunolol—ADRB2—Arf6 signaling events—AGTR1—dilated cardiomyopathy	7.35e-05	0.0335	CbGpPWpGaD
Levobunolol—ADRB1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	6.28e-05	0.0287	CbGpPWpGaD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	5.84e-05	0.0266	CbGpPWpGaD
Levobunolol—ADRB2—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	5.81e-05	0.0265	CbGpPWpGaD
Levobunolol—ADRB2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	5.71e-05	0.0261	CbGpPWpGaD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	5.68e-05	0.0259	CbGpPWpGaD
Levobunolol—ADRB2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	5.56e-05	0.0253	CbGpPWpGaD
Levobunolol—ADRB2—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	5.32e-05	0.0243	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	4.71e-05	0.0215	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	4.61e-05	0.021	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Other—CXCR3—dilated cardiomyopathy	4.14e-05	0.0189	CbGpPWpGaD
Levobunolol—ADRB1—Endothelin Pathways—RAF1—dilated cardiomyopathy	3.85e-05	0.0175	CbGpPWpGaD
Levobunolol—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	3.13e-05	0.0143	CbGpPWpGaD
Levobunolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	2.7e-05	0.0123	CbGpPWpGaD
Levobunolol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	2.59e-05	0.0118	CbGpPWpGaD
Levobunolol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	2.46e-05	0.0112	CbGpPWpGaD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	2.28e-05	0.0104	CbGpPWpGaD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	2.24e-05	0.0102	CbGpPWpGaD
Levobunolol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	2.23e-05	0.0102	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	1.98e-05	0.00902	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	1.93e-05	0.00882	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	1.84e-05	0.00838	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	1.8e-05	0.0082	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	1.74e-05	0.00794	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	1.69e-05	0.00773	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	1.69e-05	0.00773	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	1.66e-05	0.00756	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	1.66e-05	0.00756	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	1.57e-05	0.00718	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	1.54e-05	0.00703	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	1.52e-05	0.00693	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	1.49e-05	0.0068	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	1.49e-05	0.00678	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	1.44e-05	0.00658	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	1.3e-05	0.00594	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	1.29e-05	0.00588	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	1.29e-05	0.00588	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	1.27e-05	0.00581	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	1.26e-05	0.00576	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	1.26e-05	0.00576	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	1.24e-05	0.00564	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	1.2e-05	0.00547	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	1.17e-05	0.00535	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	1.14e-05	0.00518	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	9.92e-06	0.00452	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	9.7e-06	0.00443	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	9.41e-06	0.00429	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	9.17e-06	0.00418	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8.97e-06	0.00409	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	7.29e-06	0.00332	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	7.29e-06	0.00332	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	7.13e-06	0.00325	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	7.13e-06	0.00325	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	6.98e-06	0.00318	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	6.83e-06	0.00311	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.78e-06	0.00309	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.63e-06	0.00302	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.62e-06	0.00302	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.62e-06	0.00302	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.48e-06	0.00295	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.48e-06	0.00295	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	6.42e-06	0.00293	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	6.15e-06	0.00281	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	6.02e-06	0.00275	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.83e-06	0.00266	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.61e-06	0.00256	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.48e-06	0.0025	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	5.32e-06	0.00243	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	5.09e-06	0.00232	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.98e-06	0.00227	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.83e-06	0.0022	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.4e-06	0.00201	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.31e-06	0.00197	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.13e-06	0.00188	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.04e-06	0.00184	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.94e-06	0.0018	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.91e-06	0.00178	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.91e-06	0.00178	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.86e-06	0.00176	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.83e-06	0.00174	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.83e-06	0.00174	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.75e-06	0.00171	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.67e-06	0.00167	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.64e-06	0.00166	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	3.58e-06	0.00163	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.56e-06	0.00162	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	3.5e-06	0.0016	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.44e-06	0.00157	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.01e-06	0.00137	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.94e-06	0.00134	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.85e-06	0.0013	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.49e-06	0.00113	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.45e-06	0.00112	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.43e-06	0.00111	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.4e-06	0.00109	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.21e-06	0.00101	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.17e-06	0.000988	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	2.12e-06	0.000965	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	2.07e-06	0.000944	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.7e-06	0.000778	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.67e-06	0.000761	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.47e-06	0.00067	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.44e-06	0.000655	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.01e-06	0.000459	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	9.85e-07	0.000449	CbGpPWpGaD
